Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Kamrho D 300mcg Injection

Prescription Icon
Prescription Required

Marketer

Synergy Diagnostics Pvt Ltd

Salt Composition

Anti Rh D Immunoglobulin (300mcg)

Overview Kamrho D 300mcg Injection

Rho(D) immune globulin (300 mcg) injection is used to prevent the development of antibodies against the Rh D antigen. This is crucial following Rh-positive blood transfusions in Rh-negative individuals and during pregnancies where the mother is Rh-negative and the fetus Rh-positive. The injection provides Rh prophylaxis for pregnancy-related complications and is also indicated for incompatible transfusions involving Rh-negative recipients and Rh-positive red blood cells. It may also be employed in managing immune thrombocytopenic purpura, characterized by low platelet counts resulting in increased bruising. Administration is intramuscular, typically in the upper arm, and should only be performed by a healthcare professional; self-injection is strictly prohibited. Routine administration is recommended at 28 weeks gestation and within 72 hours postpartum if the infant is Rh D positive. Generally well-tolerated with minimal side effects, any adverse reactions should be immediately reported to your physician. Preventive measures or symptom mitigation strategies may be available. Prior to injection, inform your doctor of any bleeding disorders or recent/planned vaccinations.

Uses of Kamrho D 300mcg Injection

Infectious Disease Prophylaxis

Major Benefits of Kamrho D 300mcg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Kamrho D 300mcg Injection:

  • No common side effects seen

How to use Kamrho D 300mcg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Kamrho D 300mcg Injection works:

Rho(D) immune globulin, a type of immunoglobulin medication, neutralizes fetal Rh-positive red blood cells that may cross into the Rh-negative mother's bloodstream. This action prevents sensitization during events such as delivery, miscarriage, or pregnancy-related procedures causing placental bleeding.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Kamrho D 300mcg Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Kamrho D 300mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Administration of Kamrho D 300mcg Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Kamrho D 300mcg Injection.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Kamrho D 300mcg Injection to individuals with renal impairment. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Kamrho D 300mcg Injection to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Kamrho D 300mcg Injection :

Omitting a scheduled Kamrho D 300mcg Injection warrants immediate physician consultation.

Facts to Know About Kamrho D 300mcg Injection

LabelValue
Chemical Type Immunizations
Developing Habits No.
Treatment Category Immunizations

FAQs on Kamrho D 300mcg Injection

RhD-negative individuals are tested for anti-D antibodies, which attack RhD-positive red blood cells. The presence of these antibodies during pregnancy poses a risk of rhesus disease to the developing fetus.
Kamrho D 300mcg Injection prevents Rhesus disease by avoiding sensitization in RhD-negative women exposed to RhD-positive blood, thus preventing their immune system from reacting.
Kamrho D 300mcg Injection must be administered intramuscularly, typically in the upper arm, by a qualified healthcare professional only. Never self-inject. Strictly follow your doctor's instructions for optimal results.
If your baby is RhD positive, you'll receive a Kamrho D 300mcg injection at 28 weeks pregnant and again within 72 hours of birth. Always consult your doctor before receiving this injection.
Kamrho D 300mcg Injection
2,341
MRP 2,580
9% off